Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beve⦠read more
Healthcare
Drug ManufacturersāSpecialty & Generic
13 years
CAD
Exclusive to Premium users
$1.80
Price-12.62%
-$0.26
$362.453m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$268.995m
-
1y CAGR-
3y CAGR-
5y CAGR-$598.115m
-
1y CAGR-
3y CAGR-
5y CAGR-$5.62
-
1y CAGR-
3y CAGR-
5y CAGR$487.213m
$917.701m
Assets$430.488m
Liabilities$348.397m
Debt38.0%
-0.7x
Debt to EBITDA-$177.030m
-
1y CAGR-
3y CAGR-
5y CAGR